+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 2Years +
All Genders
ID07227805

Safety and Performance Evaluation of the New Medtronic MiniMed NMX8 Automated Insulin Delivery System Compared to the MiniMed 780G System in People with Insulin-Requiring Diabetes

Led by Medtronic MiniMed, Inc. · Updated on 2026-09-21

116

Participants Needed

9

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the safety and performance of a new automated insulin delivery device called the MiniMed NMX8 system in people living with insulin-requiring diabetes. This study compares the MiniMed NMX8 system with the already available MiniMed 780G system. It is a pre-market, open-label, randomized controlled trial involving multiple centers and aims to assess how well the new system works and its safety profile. The study has two main parts a run-in phase and a study phase. During the run-in phase, all participants use the MiniMed 780G system in Auto Mode while collecting baseline glucose data with the Simplera Sync sensor. After this, participants are randomly assigned to either continue using the MiniMed 780G system or switch to the MiniMed NMX8 system for 12 weeks, with all continuing to use the Simplera Sync sensor throughout the study. Participants are involved in training sessions and must be capable of operating the study devices and adhering to the visit schedule. Throughout the 12-week study phase, researchers monitor various outcomes including safety and device performance. The primary outcome is assessed during the study phase, along with several secondary outcomes measured at the end and during the study. The entire process involves ongoing monitoring of glucose data and insulin delivery to evaluate the new system under real-world conditions.

CONDITIONS

Brief Title

Evaluation of the Safety and Performance of the Novel Medtronic Experimental Automated Insulin Delivery System (NMX8) in People Living With Diabetes (NEXUS)

Research Team

R

Renée Tillie, PhD

B

Bérangère Lacroix

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here